+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
All Ages
All Genders
ID07576660

Multicenter Randomized Trial Comparing Dexamethasone Versus Placebo for Sepsis-Associated Acute Respiratory Distress Syndrome

Led by Southeast University, China · Updated on 2026-09-02

1704

Participants Needed

2

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the effects of dexamethasone in patients with acute respiratory distress syndrome ARDS caused by sepsis, including pneumonia and extrapulmonary sepsis, which are common and serious causes of this lung condition in critically ill patients. This trial aims to determine whether dexamethasone combined with usual care can reduce the risk of death within 90 days compared to placebo with usual care. ARDS is characterized by inflammation that damages the lungs and impairs breathing, and while glucocorticoids like dexamethasone may help reduce inflammation, their impact on survival is still uncertain. Participants will be randomly assigned to receive either dexamethasone or a placebo, both given alongside standard care. The dexamethasone group will receive 20 mg intravenously soon after randomization, followed by 20 mg once daily through day 5, then 10 mg once daily from day 6 to day 10. The placebo group will receive a matching saline injection on the same schedule. This treatment period lasts up to 10 days. During the study, participants will be closely monitored with assessments including survival status at 90 days, ventilator use, vasopressor use, kidney therapy, and mortality at various time points up to 12 months. Additional evaluations include cognitive and psychological assessments as well as quality of life and daily functioning questionnaires conducted at 90 days, 6 months, and 12 months after randomization. The studys total duration extends through these follow-up periods to gather comprehensive outcome data.

CONDITIONS

Brief Title

Dexamethasone Treatment for Sepsis-associated Acute Respiratory Distress Syndrome: a Multicenter, Randomised, Double-blinded, Controlled Trial

Research Team

H

Hui Chen, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here